Recormon_ 30 000 Iu/0.6 M_ Injection IU/0.6 m_ Injection

Recormon_ 30 000 Iu/0.6 M_ Injection IU/0.6 m_ Injection

S4
PDF Leaflet Revision Date: 12 August 2022

API: Epoetin Beta | Company: Roche Products

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of renal anaemia and prevention of anaemia of prematurity.

Dosage (summary)

Initial: 3 x 20 IU/kg/week (subcutaneous); max: 720 IU/kg/week.

Onset of Action / Duration

Onset: 12-28 hours, Duration: 4-28 hours.

Special Populations

  • Renal impairment
  • Cancer patients
  • Premature infants

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Contraindications

  • Hypersensitivity to epoetin beta
  • Poorly controlled hypertension
  • Recent myocardial infarction or stroke

Common side effects

  • Hypertension
  • Headache
  • Thromboembolic events

Counselling Points

  • Monitor haemoglobin and platelets regularly
  • Avoid use in pregnancy
  • Report any severe headaches or vision changes

Serious warnings

  • Increased mortality in cancer patients
  • Monitor blood pressure
  • Risk of Pure Red Cell Aplasia

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Recormon_ 30 000 Iu/0.6 M_ Injection IU/0.6 m_ Injection
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW